Literature DB >> 8904958

Synovial fluid levels of proinflammatory interleukins and their inter-relationships in elderly vs younger onset rheumatoid arthritis.

L Punzi1, N Bertazzolo, M Pianon, E Rizzi, P Rossini, S Todesco.   

Abstract

Elderly-onset rheumatoid arthritis (EORA) is thought to be different from younger-onset disease (YORA) for many reasons, including a more elevated acute phase response and a more abrupt onset; both events are mainly regulated by pro-inflammatory interleukins (ILs), in particular, IL-1, IL-6 and IL-8. To compare the synovial fluid (SF) levels of these ILs, and their relationship to local inflammation as well as the acute phase response, erythrocyte sedimentation rate (ESR) and serum C-reactive protein (CRP) in the two RA subsets, we determined white blood cell (WBC) number, total protein (TP), IL-1beta, IL-6 and IL-8 concentrations in the SF of 50 patients, 15 with EORA and 35 with YORA. Both ESR and CRP were higher in EORA than in YORA. IL-6 was higher in SF of EORA (2111.37 +/- 1425.03 pg/mL) than YORA (1077.53 +/- 757.62 pg/mL, p = 0.002), while no difference was observed for SF IL-1beta and IL-8. There was a weak correlation between SF IL-6 and IL-1beta in EORA, whereas SF ILs and CRP and/or ESR did not show any correlation in both groups. Our study indicates that in EORA, as in other diseases occurring in the elderly, there are elevated levels of IL-6. Higher SF levels of IL-6 may be, at least in part, responsible for the different behavior of EORA with respect to YORA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8904958     DOI: 10.1007/bf03339579

Source DB:  PubMed          Journal:  Aging (Milano)        ISSN: 0394-9532


  3 in total

Review 1.  An autumn tale: geriatric rheumatoid arthritis.

Authors:  Senol Kobak; Cemal Bes
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-11-07       Impact factor: 5.346

2.  Clinical and laboratory manifestations of elderly onset psoriatic arthritis: a comparison with younger onset disease.

Authors:  L Punzi; M Pianon; P Rossini; F Schiavon; P F Gambari
Journal:  Ann Rheum Dis       Date:  1999-04       Impact factor: 19.103

Review 3.  Tumour necrosis factor-alpha antagonists in the management of rheumatoid arthritis in the elderly: a review of their efficacy and safety.

Authors:  Beáta J Radovits; Wietske Kievit; Roland F J M Laan
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.